"10.1371_journal.pone.0060933","plos one","2013-04-17T00:00:00Z","Modesto J Remui침치n; Esther P칠rez-Herr치n; Joaqu칤n Rull치s; Carlos Alemparte; Mar칤a Mart칤nez-Hoyos; David J Dow; Johnson Afari; Nalini Mehta; Jorge Esquivias; Elena Jim칠nez; F치tima Ortega-Muro; Mar칤a Teresa Fraile-Gabald칩n; Vickey L Spivey; Nicholas J Loman; Mark J Pallen; Chrystala Constantinidou; Douglas J Minick; M칩nica Cacho; Mar칤a Jos칠 Rebollo-L칩pez; Carolina Gonz치lez; Ver칩nica Sousa; I침igo Angulo-Barturen; Alfonso Mendoza-Losana; David Barros; Gurdyal S Besra; Llu칤s Ballell; Nicholas Cammack","Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain; Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom; School of Biosciences, University of Birmingham, Edgbaston, United Kingdom; Department of Analytical Chemistry, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America","Conceived and designed the experiments: MJR EPH JR CA DJD EJ FOM MTFG IAB AML DB GSB LB NC. Performed the experiments: EPH JR CA MMH JA NM JE DJM MC MJRL CG VS. Analyzed the data: EPH JR JA NM FOM VLS NJL MJP CC DJM. Contributed reagents/materials/analysis tools: MC JE. Wrote the paper: MJR GSB LB.","The authors declare the following co-authors Modesto J. Remui침치n, Esther P칠rez-Herr치n, Joaqu칤n Rull치s, Carlos Alemparte, Maria Martinez-Hoyos, David J. Dow, Johnson Afari, Nalini Mehta, Jorge Esquivias, Elena Jim칠nez, F치tima Ortega-Muro, Mar칤a Teresa Fraile-Gabald칩n, Vickey L. Spivey, Douglas J. Minick, M칩nica Cacho, Mar칤a Jose Rebollo-Lopez, Carolina Gonzalez, Ver칩nica Sousa, I침igo Angulo- Barturen, Alfonso Mendoza-Losana, David Barros, Llu칤s Ballell and Nicholas Cammack are employed by GlaxoSmithKline. However, this does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. They also declare there is the following public patent (WO2012143522, Tetrahydropyrazolo [1,5-A] pyrimidine as anti-tuberculosis compounds, 20 April 2012) relating to material pertinent to this article. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Modesto J Remui침치n","MJR",27,TRUE,14,12,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
